Fact-checked by Grok 2 weeks ago

Encephalomalacia

Encephalomalacia is a pathological condition characterized by the softening or loss of tissue, typically resulting from , ischemia, , craniocerebral , or other injurious events to the . The term "encephalomalacia," derived from etymology meaning "softening of the ," has been used since the to describe such gross pathological changes. This irreversible damage leads to the replacement of healthy neural tissue with softer, gliotic or cystic spaces, often visible on as areas of hypodensity or encephalatrophic changes. The causes of encephalomalacia are diverse and depend on the patient's age and underlying risk factors; in adults, common etiologies include , cerebrovascular accidents such as ischemic strokes or hemorrhages, and severe infections like , while in children, hypoxic-ischemic , perinatal trauma, intracranial infections, and prematurity are predominant triggers. Symptoms vary based on the location, extent, and laterality of the affected brain regions but frequently manifest as neurological deficits, including motor impairments such as or , speech and developmental delays, or seizures, visual or auditory disturbances, cognitive issues like memory loss or psychomotor retardation, and behavioral changes. Diagnosis primarily relies on magnetic resonance imaging (MRI) or computed tomography (CT) scans, which reveal characteristic lesions such as cystic formations or tissue cavitation, often confirmed through clinical correlation with history of insult and neurological examination. There is no curative treatment for encephalomalacia, as the neuronal loss is permanent; management focuses on symptomatic relief and rehabilitation, including anticonvulsant medications for seizures, physical and occupational therapy to improve motor function, speech therapy for communication deficits, and multidisciplinary support to mitigate long-term disabilities and enhance quality of life. Prognosis depends on the lesion's size, location, and timeliness of intervention, with smaller or strategically less critical areas potentially allowing for partial functional compensation through neuroplasticity, though widespread involvement often results in chronic neurological impairment.

Overview

Definition

Encephalomalacia refers to the localized softening and degeneration of brain tissue, specifically the loss of brain parenchyma resulting from liquefactive necrosis. This process leads to the formation of cystic cavities within the brain that are filled with a fluid resembling cerebrospinal fluid (CSF). The condition represents a chronic, irreversible alteration of cerebral structure, where necrotic tissue is resorbed, leaving behind these fluid-filled spaces and often resulting in permanent reduction in brain volume. Unlike , which involves the proliferation of glial cells to form a that preserves the underlying architecture despite , encephalomalacia entails substantial parenchymal destruction and cavity formation without such structural preservation. It also differs from , a related but distinct entity characterized by cystic lesions that directly communicate with the or subarachnoid space, often arising congenitally. Encephalomalacia may occur with or without surrounding at its margins, depending on the extent of the original insult and the brain's reparative response. The term "encephalomalacia" originates from roots denoting the softening of the (en- "in," kephalē "head," malakia "softness").

Historical background

The concept of encephalomalacia, or cerebral softening, emerged in the early through postmortem examinations that revealed areas of tissue disintegration. Léon Rostan provided one of the earliest systematic descriptions in his 1819 work Recherches sur le ramollissement du cerveau, where he distinguished "ramollissement" (softening) as a distinct pathological entity separate from or , characterizing it as a primary often presenting with initial nonspecific symptoms followed by focal neurological deficits. This marked a shift from earlier vague references to brain dissolution in the , establishing ramollissement as a recognizable gross pathological finding in studies. Building on Rostan's foundation, pathologist Jean Cruveilhier further advanced the understanding in his multivolume Anatomie pathologique du corps humain (1829–1842), where he illustrated and detailed cases of brain softening associated with vascular disruptions, emphasizing its macroscopic appearance as yellowish or reddish softened areas amid otherwise normal tissue. Early 19th-century case reports, including those by Richard Bright in his Reports of Medical Cases (1827), linked cerebral softening to ischemic events like and , as well as traumatic injuries, highlighting its role in post- paralysis and hemiplegia. These observations were corroborated in clinical-pathological correlations from the 1830s and 1840s, such as Abercrombie's descriptions of softening following . By the mid-19th century, the term "encephalomalacia" entered as a Latinized equivalent to ramollissement, derived from roots enkephalos () and malakia (softening), reflecting the condition's recognition as a of rather than an inflammatory process alone. Historical accounts from this era also documented cases in infants, where softening was attributed to perinatal asphyxia or birth-related insults, as reviewed in later pathological summaries that traced such findings back to 19th-century autopsies. Initial interpretations often implicated direct mechanical during labor as the primary cause, a view prevalent in early obstetric reports, though subsequent analyses in the late 19th and early 20th centuries reframed it as a post-necrotic outcome of hypoxic-ischemic or vascular events, correcting earlier causal assumptions through refined etiological insights.

Pathophysiology

Mechanisms of tissue softening

Encephalomalacia primarily arises through liquefactive necrosis, a process in which dead neural tissue is enzymatically digested into a liquid viscous mass. This digestion is mediated by hydrolytic enzymes released from lysosomes of infiltrating neutrophils and macrophages, which break down cellular structures, proteins, and lipids, resulting in tissue softening and liquefaction. In the central nervous system, this form of necrosis is characteristic due to the high lipid content of neural tissue and the abundance of hydrolytic enzymes, leading to rapid dissolution of the necrotic area without the formation of a firm scar initially. The initiation of this softening often stems from hypoxia or ischemia, which disrupts cellular homeostasis and triggers a cascade of pathological events. Hypoxic conditions cause rapid cellular swelling through cytotoxic edema, driven by failure of ion pumps and influx of sodium and water into neurons and glia. Concurrently, mitochondrial dysfunction impairs ATP production, exacerbating energy failure and promoting the release of excitotoxic neurotransmitters such as glutamate from damaged neurons. This glutamate surge overactivates NMDA receptors, leading to calcium overload, further mitochondrial damage, and ultimately a mix of apoptosis in the penumbra and necrosis in the core of the affected region. Following the acute phase of , reactive ensues as a reparative response, involving proliferation and hypertrophy of and around the softened area. upregulate (GFAP) and form a dense that encapsulates the liquefied tissue, isolating it from surrounding healthy brain matter to limit further damage. contribute by phagocytosing debris and releasing cytokines, though this scar is permeable to neurotoxic factors, potentially perpetuating chronic inflammation and . This gliotic barrier prevents complete tissue resolution, contributing to the persistent structural changes observed in encephalomalacia.

Associated pathological changes

Encephalomalacia arises as a of necrotic following various insults, leading to secondary structural alterations that reshape the affected regions. One prominent pathological change is the development of multicystic spaces or encephalomalacic cavities, which form through the expansion of liquefactive necrotic areas into fluid-filled cysts lined by reactive cells. These cavities often contain (CSF)-like material and exhibit imaging characteristics mimicking CSF signal intensity, such as on T2-weighted MRI sequences. The resultant loss causes compensatory enlargement of the , known as ex vacuo , where the ventricles dilate due to the absence of surrounding rather than obstructive . Reactive gliosis and represent key cellular responses surrounding these cavities, where proliferate and deposit components to form a dense . This scar encapsulates the necrotic zone, serving as a physical barrier that impedes axonal regeneration and synaptic reconnection in the damaged area. Additionally, the can disrupt normal neuronal circuitry, potentially acting as an epileptogenic focus by fostering hyperexcitability through inflammatory mediators and altered expression. In chronic stages, encephalomalacia may involve associated in perilesional tissues, resorption of prior hemorrhages leaving deposits, and within the softened , all of which further distort architecture. These changes contribute to the resolution of any initial as necrotic tissue liquefies and atrophies, resulting in a shrunken, irregular of the affected lobe or .

Causes

Ischemic and vascular causes

Ischemic strokes represent the predominant vascular of encephalomalacia, comprising the majority of cases since they account for 82–92% of all strokes. These events typically arise from thrombotic occlusion within due to or , embolic blockage from cardiac or proximal arterial sources, or systemic hypoperfusion during , all of which deprive of oxygen and nutrients, culminating in and subsequent softening. Infarctions most commonly affect the territory, which supplies large portions of the , , and , leading to localized encephalomalacia in these regions. Hemorrhagic strokes, while less frequent than ischemic ones, also drive encephalomalacia through rupture of cerebral vessels, often precipitated by chronic hypertension or aneurysmal weaknesses, resulting in extravasation of blood that directly destroys neural via mechanical compression and enzymatic degradation from hemoglobin breakdown products. This primary injury is compounded by secondary ischemia, as the expanding impairs adjacent blood flow and triggers vasogenic , further promoting tissue liquefaction in affected areas. Anatomical anomalies in the Circle of Willis, such as hypoplasia of its components, predispose individuals to encephalomalacia by creating imbalances in cerebral perfusion that exacerbate ischemic vulnerability during vascular insults. For example, hypoplasia of the —a common variant found in approximately 34% of patients evaluated for cerebrovascular issues—can lead to uneven collateral circulation and focal areas of softening.

Traumatic causes

Traumatic causes of encephalomalacia primarily involve mechanical forces that disrupt brain tissue integrity, leading to and subsequent softening. These injuries often result from direct impacts or acceleration-deceleration forces applied to the head, causing immediate cellular damage that evolves into focal or diffuse areas of encephalomalacia over time. Common mechanisms include hemorrhagic contusions, where bleeding into brain parenchyma triggers and resorption, forming cystic cavities lined by typically 6-12 months post-injury. (DAI), another frequent outcome of high-velocity , involves widespread shearing of tracts, leading to secondary degeneration and encephalomalacic changes in subcortical regions, , and by around 3 months. Head trauma from accidents, falls, or assaults is a leading precipitant, often producing contusions in coup-contrecoup patterns or subdural hematomas that compress and necrotize underlying tissue. For instance, collisions frequently cause and associated encephalomalacia due to rotational forces, with imaging revealing hyperintense cystic lesions on MRI. In severe cases, such as abusive head trauma in children, shaking or impact can result in multicystic encephalomalacia, characterized by numerous loculated pseudocysts replacing large portions of cerebral , as seen in autopsy-confirmed cases surviving 27-993 days post-injury. These injuries may also induce secondary vascular compromise, exacerbating tissue softening through ischemia in the perilesional zones. Surgical or iatrogenic represents another significant category, where procedural interventions inadvertently damage , leading to localized and encephalomalacia. Post-craniotomy complications, such as those following tumor resection or ventricular shunting, can cause focal softening due to direct parenchymal disruption or formation. A notable example is penetrating injury during , which has been reported to produce encephalomalacia through unintended penetration, resulting in loss and . In perinatal contexts, head —though less common than hypoxic-ischemic events—is a recognized cause, particularly in cases of birth-related injury or non-accidental , exploiting the vulnerability of the immature and underdeveloped sutures. This can manifest as cystic encephalomalacia with gliotic margins, often detected via in the neonatal period. susceptibility amplifies the risk, as mechanical forces during delivery or inflicted readily translate to diffuse parenchymal softening.

Infectious and inflammatory causes

Infectious processes can directly contribute to encephalomalacia through the invasion of microbial pathogens into brain tissue, resulting in localized or diffuse necrosis and subsequent softening. Bacterial infections, such as those causing cerebral abscesses, are a prominent example; pathogens like Staphylococcus aureus spread hematogenously or from contiguous sites, leading to suppurative inflammation, pus formation, and liquefactive necrosis of the surrounding parenchyma. This necrotic tissue undergoes gliosis and cavitation over time, manifesting as focal encephalomalacia on imaging, particularly in immunocompromised individuals or those with predisposing conditions like endocarditis. Viral infections, exemplified by (HSV) , induce encephalomalacia via necrotizing inflammation predominantly affecting the temporal and frontal lobes. HSV type 1, the most common culprit, triggers acute cytotoxic and hemorrhagic , which evolves into cystic softening if the patient survives the initial insult. In severe cases, such as neonatal or intrauterine infections, this can result in multicystic encephalomalacia with , contributing to long-term neurological deficits. Inflammatory conditions without direct microbial involvement also drive encephalomalacia by promoting chronic tissue destruction. In multiple sclerosis (MS), acute flares or relapses lead to inflammatory demyelination within plaques, where repeated episodes of perivascular cause axonal loss and eventual necrotic softening, appearing as cystic or hypointense lesions on MRI. Similarly, vasculitis, such as primary angiitis of the CNS, incites immune-mediated vessel wall , resulting in multifocal ischemia, , and secondary encephalomalacia due to unresolved parenchymal damage.00248-4/pdf) Toxic exposures and systemic inflammatory states further exacerbate encephalomalacia through indirect mechanisms. poisoning, for instance, produces metabolites that inhibit mitochondrial function, causing bilateral putaminal and diffuse softening, often detectable as encephalomalacia months post-exposure. In , hypoxic-ischemic events secondary to systemic hypoperfusion and can induce widespread brain injury, culminating in cystic encephalomalacia, especially in pediatric cases with intracranial involvement. Severe infections may overlap with vascular ischemia, amplifying necrotic softening through combined inflammatory and hypoperfusion effects.

Classification

Encephalomalacia has been traditionally classified based on gross pathological appearance into three types distinguished by color, though these terms are historical and less commonly used in contemporary imaging-focused diagnostics.

Red softening

Red softening represents the hemorrhagic variant of encephalomalacia, characterized by the of into necrotic brain tissue, resulting in a distinctive red discoloration due to the presence and subsequent breakdown of erythrocytes. This form arises primarily in hemorrhagic infarcts, where reperfusion or collateral flow reintroduces erythrocytes into areas of ischemic damage, leading to petechial hemorrhages that permeate the softened . It is most commonly observed in embolic strokes affecting gray matter-rich regions supplied by the , where dual vascular supply from leptomeningeal collaterals facilitates leakage into compromised tissue. Pathologically, red softening involves the accumulation of extravascular blood within the infarcted zone, triggering a of tissue changes including erythrocyte and the release of hemoglobin-derived pigments. This leads to deposition as macrophages infiltrate the area to phagocytose degraded red blood cells and necrotic debris, contributing to chronic inflammation and . Over time, the process progresses to cystic encephalomalacia, where the liquefied tissue forms fluid-filled cavities bordered by reactive , distinguishing it from non-hemorrhagic variants through the presence of hemorrhagic residues. In acute clinical settings, red softening is prevalent following , such as after thrombolytic therapy in ischemic , where blood-brain barrier disruption and exacerbate and hemorrhage. This contrasts with pale infarcts, which lack significant blood and appear anemic due to pure ischemic necrosis without reperfusion-mediated bleeding. Such hemorrhagic changes are often linked to underlying vascular causes like embolic , underscoring the role of abrupt and subsequent flow restoration in its .

White softening

White softening, also known as anemic or pale , represents an ischemic variant of degeneration characterized by a pale appearance on gross pathological examination due to the absence of hemorrhage. This form predominantly affects regions, where ischemic leads to softening without blood infiltration, distinguishing it from hemorrhagic types. The mechanism begins with an anemic infarct resulting from inadequate blood supply, often via global hypoperfusion or of small penetrating vessels, causing initial coagulation necrosis of neurons, , and myelinated fibers. This progresses to , where enzymatic digestion by macrophages and results in tissue liquefaction and cyst formation, but without the red staining from extravasated blood seen in reperfused infarcts. is particularly vulnerable due to its reliance on long, end-arterial vessels with limited collateral flow, leading to selective and softening in affected areas. It commonly arises in watershed zones between major cerebral arterial territories, where hypoperfusion from systemic is most severe, or in states of chronic hypoperfusion such as following . Ischemic causes like small-vessel disease contribute to this non-hemorrhagic softening, often manifesting as leukoencephalomalacia with eventual and .

Yellow softening

Yellow softening represents a suppurative variant of encephalomalacia characterized by inflammatory destruction, primarily linked to pyogenic infections or brain abscesses where accumulation imparts a distinctive yellow hue to the affected . This coloration arises from the presence of purulent composed of neutrophils, cellular debris, and liquefied necrotic material, distinguishing it from the dry, anemic observed in white softening. The pathological progression begins with the formation of a pyogenic , where bacterial —often from contiguous spread of —triggers acute and subsequent suppuration. This leads to enzymatic digestion of by neutrophil-derived proteases, resulting in and the erosion of neural structures into malacic cavities filled with fibrinoid material and residual inflammatory debris. Over time, these cavities may become encapsulated by fibrous , though persistent suppuration can perpetuate ongoing malacia if untreated. Unlike red softening, which stems from hemorrhagic , yellow softening emphasizes purulent without primary vascular rupture. In contemporary medical practice, yellow softening is rare owing to widespread prophylaxis and , which have drastically reduced the incidence of pyogenic brain abscesses to approximately 0.3–1.3 cases per 100,000 persons annually. However, it persists in immunocompromised individuals, such as those with , , or undergoing immunosuppressive therapy, where opportunistic pathogens more readily cause suppurative lesions. This variant underscores the intersection of infectious causes, as detailed in broader discussions of encephalomalacia .

Clinical Manifestations

Symptoms and signs

Encephalomalacia manifests through a variety of neurological deficits that are predominantly determined by the location and severity of the affected tissue. Lesions in the often produce motor impairments, such as or , alongside alterations in executive function and personality. Involvement of the typically results in cognitive deficits like memory loss or , whereas damage may lead to sensory disturbances, including hemisensory loss or neglect syndromes. encephalomalacia can cause visual field defects, such as homonymous hemianopia. Common signs associated with encephalomalacic lesions include seizures, which may be focal or generalized and frequently originate from surrounding gliotic acting as an epileptogenic focus. Headaches are also prevalent, particularly in cases with associated increased or vascular components. or other language impairments occur when perisylvian regions are affected, and sensory-motor coordination issues may arise from involvement. In extensive or bilateral cases, encephalomalacia can present with profound neurological compromise, including altered , , or progression to a persistent due to widespread parenchymal loss. The clinical presentation varies between acute and chronic stages: acutely, symptoms often resemble those of an ischemic , with sudden onset of focal , , or sensory deficits following the inciting event. Over time, these evolve into more stable but permanent neurological impairments in the chronic phase, characterized by and cystic changes.

Progression in different age groups

The pathological process leading to encephalomalacia typically evolves through acute, subacute, and chronic phases following the initial brain insult. In the acute phase, which unfolds within hours to days, affected tissue experiences liquefactive necrosis and associated edema, leading to softening of the parenchyma. The subacute phase, spanning days to weeks, involves further tissue breakdown and liquefaction, with imaging revealing areas that mimic cerebrospinal fluid signals on MRI sequences such as low T1 and high T2 intensity. By the chronic phase, occurring over months to years, the necrotic regions evolve into cystic cavities surrounded by gliosis and result in permanent volume loss of brain parenchyma. In neonates and infants, progression is often rapid and severe, frequently resulting in multicystic encephalomalacia characterized by multiple loculated pseudocysts forming in the cerebral and within weeks to months after onset. This form typically emerges from extensive early-life insults and leads to and , with diagnosis occurring by an average of 70 days post-onset, while neurological manifestations such as developmental delays often appear years later. Common manifestations include speech and motor developmental delays (66%), (62%), (54%), and limb (32%). Although the immature brain demonstrates heightened —facilitated by ongoing and network remodeling—extensive multicystic involvement often overwhelms compensatory mechanisms, yielding profound motor and cognitive impairments. In adults, encephalomalacia advances more gradually, with the shift from acute to chronic gliotic cysts and unfolding over several months to years, as seen in cases of post-traumatic injury where neuropsychiatric decline intensifies insidiously. Limited in mature brains hinders robust recovery, increasing susceptibility to ongoing symptoms like seizures and exacerbating comorbidities, though focal lesions may allow partial functional adaptation in some instances.

Diagnosis

Imaging modalities

Magnetic resonance imaging (MRI) serves as the gold standard for diagnosing encephalomalacia due to its superior soft tissue contrast and ability to delineate chronic parenchymal changes. On MRI, areas of encephalomalacia appear as cystic lesions that follow (CSF) signal intensity across sequences, manifesting as hypointense on T1-weighted images and hyperintense on T2-weighted and (FLAIR) sequences, with FLAIR suppression due to the CSF-like content. Surrounding typically presents as T2 and FLAIR hyperintensity, reflecting reactive astrocytic proliferation at the lesion margins. Diffusion-weighted imaging (DWI) and apparent diffusion coefficient (ADC) maps in chronic encephalomalacia demonstrate within the cystic regions, indicating free water movement in the liquefied tissue, in contrast to restricted diffusion seen in acute insults. Computed tomography () is a valuable initial imaging modality, particularly in acute settings, for detecting encephalomalacia, though it is less sensitive for subtle chronic alterations compared to MRI. CT reveals hypodense lesions with attenuation values slightly higher than CSF, accompanied by focal volume loss, ex vacuo ventricular dilation, and associated features such as or manifesting as linear hypodensities. It excels in identifying acute complications like hemorrhage, appearing as hyperdense areas within or adjacent to the . Advanced imaging techniques provide additional insights into the functional and microstructural impacts of encephalomalacia. Diffusion tensor imaging (DTI) is particularly useful for assessing tract disruption, revealing reduced and altered in perilesional fibers due to axonal damage and , which conventional MRI may overlook. (PET), often using 18F-fluorodeoxyglucose (FDG), demonstrates metabolic inactivity in affected regions as focal hypometabolism, correlating with neuronal loss and gliotic scarring, and aiding in evaluating remote effects on function.

Histological confirmation

Histological confirmation of typically involves microscopic examination of tissue obtained post-mortem or during surgical , revealing characteristic features of chronic . Microscopically, there is prominent loss of neurons and within the affected regions, accompanied by the formation of cystic spaces filled with liquefied debris and cerebrospinal fluid-like material. These cysts are often lined by foamy macrophages that phagocytose lipid-laden debris from necrotic tissue, alongside reactive characterized by hypertrophic, GFAP-positive forming a at the borders. Standard hematoxylin and eosin (H&E) highlights the liquefied necrotic debris, pallor of the , and surrounding with microglial activation in the subacute phase transitioning to chronic cystic change. In cases of red softening due to hemorrhagic , Prussian blue demonstrates hemosiderin-laden macrophages, indicating prior blood breakdown products. For yellow softening variants associated with , Gram can identify bacterial organisms within the suppurative necrotic material, aiding in etiological confirmation. Differentiation from acute necrosis is based on the absence of cystic and foamy macrophages in the former, which instead shows neutrophilic infiltration and early dissolution without organized . In contrast to neoplastic processes, encephalomalacia lacks infiltrative cells; tumors may present cavitary changes but retain viable neoplastic elements, whereas encephalomalacia features clean-walled cysts bordered solely by gliotic . These histological patterns often correlate with findings, such as cystic lesions on MRI.

Management

Treatment of underlying cause

The treatment of encephalomalacia focuses on addressing the precipitating to prevent further tissue softening and progression of damage. For cases resulting from ischemic events, such as acute ischemic stroke, intravenous with (tPA) is administered within a 4.5-hour window from symptom onset to dissolve clots and restore cerebral blood flow, provided there are no contraindications like recent hemorrhage. Endovascular , involving mechanical clot removal via , is recommended for patients with large-vessel occlusions, extending eligibility up to 24 hours in select cases based on imaging, to achieve recanalization and limit infarct expansion. For secondary prevention in ischemic etiologies, antiplatelet therapy with aspirin (typically 81-325 mg daily) is initiated to reduce the risk of recurrent and further ischemic insults. In traumatic causes, such as those involving intracranial s from , prompt surgical evacuation is the primary intervention to relieve and halt secondary ischemic softening of surrounding brain tissue. Techniques include or to remove the hematoma, with timing ideally within hours of diagnosis to optimize outcomes and prevent progression to encephalomalacia. For infectious etiologies, such as bacterial , broad-spectrum intravenous antibiotics like combined with third-generation cephalosporins (e.g., ) are used empirically to target pathogens and resolve the infection driving tissue . In viral infections like , acyclovir is administered intravenously at high doses (10 mg/kg every 8 hours) to inhibit viral replication and mitigate inflammatory damage leading to softening. For vascular anomalies, such as unruptured or ruptured intracranial s contributing to ischemia or hemorrhage, is a that deploys platinum coils to occlude the sac and prevent rupture or . In cases linked to , (e.g., high-intensity 80 mg daily) is employed for to stabilize plaques and reduce the risk of recurrent vascular events exacerbating encephalomalacia. These etiology-specific interventions aim to stabilize the condition, with supportive care addressing immediate sequelae as needed.

Symptomatic and supportive care

Symptomatic and supportive care for encephalomalacia primarily addresses the irreversible loss of brain tissue by targeting associated neurological deficits and preventing secondary complications, as no therapies can regenerate the damaged areas as of 2025. Seizures, a frequent sequela due to cortical irritation from softened tissue, are managed with antiepileptic drugs such as levetiracetam, which has shown efficacy in controlling post-traumatic epilepsy with a favorable side-effect profile in both adults and children. In the acute phase following insults like trauma or ischemia, neuroprotective measures including therapeutic hypothermia may be initiated to mitigate further neuronal injury, particularly in cases of hypoxic-ischemic encephalopathy leading to encephalomalacia. Intensive care unit (ICU) support plays a critical role for patients presenting with coma or respiratory compromise, where mechanical ventilation is employed to maintain oxygenation and cerebral perfusion while avoiding hyperventilation-induced vasoconstriction. Guidelines from the European Society of emphasize lung-protective ventilation strategies, such as low tidal volumes and moderate , to reduce ventilator-associated complications in acute injury patients. Rehabilitation forms the cornerstone of long-term management through a multidisciplinary approach tailored to individual deficits. Physical and occupational focus on restoring motor and independence in , with from case studies demonstrating improvements in and coordination in adults with traumatic encephalomalacia. Cognitive addresses impairments in , , and , while speech-language targets and communication challenges, enhancing quality of life post-injury. Psychological support, including psychiatric evaluation, is essential for managing and emotional disorders arising from cognitive and social limitations.

Prognosis

Factors influencing outcomes

The outcomes in cases of encephalomalacia are profoundly shaped by the location and extent of the cerebral lesions. Lesions situated in eloquent regions, such as the , typically result in more pronounced and persistent neurological deficits due to the critical functions they subserve, whereas those in relatively silent areas, like portions of the , often permit greater compensatory mechanisms and better overall recovery. The size and multiplicity of lesions further dictate severity; smaller, focal lesions facilitate neural plasticity and adaptation, leading to improved functional prognosis, while larger or multifocal encephalomalacia correlates with heightened and poorer long-term outcomes. Age at the time of and the developmental stage of the represent key determinants of recovery potential. Infants and young children benefit from heightened , which enables more effective reorganization of neural networks and superior functional compensation compared to adults, though severe encephalomalacia in this group is associated with elevated mortality rates, particularly when stemming from hypoxic-ischemic events. Adults, conversely, experience diminished plasticity, resulting in more enduring impairments, compounded by age-related declines in regenerative capacity. Pre-existing comorbidities significantly exacerbate the progression and of encephalomalacia, especially in ischemic etiologies. Diabetes mellitus impairs vascular integrity and amplifies tissue damage, leading to worse discharge outcomes, higher mortality, and increased recurrence risk post-. Similarly, promotes and , worsening ischemic insults and contributing to more extensive encephalomalacic changes with diminished recovery odds. Early therapeutic intervention in the acute phase, exemplified by within 3 hours of onset, markedly enhances by mitigating and significantly reducing the risk of significant disability at 3-6 months.

Long-term complications

Encephalomalacia, characterized by irreversible softening and loss of brain tissue, leads to a range of chronic neurological deficits that persist indefinitely due to the absence of regenerative capacity in mature brain parenchyma. As of 2025, no therapeutic interventions exist to reverse the tissue damage, resulting in lifelong structural and functional impairments that vary by location, extent, and underlying . Among neurological complications, chronic is prominent, arising from gliotic that forms epileptogenic foci. Studies report prevalence ranging from 37% in pediatric cohorts with encephalomalacia to 62% in cases of cystic encephalomalacia, with risks elevated in multifocal lesions or those from hypoxic-ischemic events. may develop secondary to , creating compensatory ventricular enlargement (hydrocephalus ex vacuo), and necessitates shunting in symptomatic instances. and , affecting motor control, manifest in children with cystic forms, with occurring in 54% of cases, often linked to or involvement. Cognitive and psychosocial sequelae include progressive decline resembling , with intellectual impairment and developmental delays reported in 66% of affected children, impairing , executive function, and learning. and behavioral changes, such as or , emerge in association with frontal or temporal lesions, contributing to reduced and . Dependency in is common, with 30-70% of individuals experiencing moderate to severe , particularly following etiologies, leading to long-term reliance on caregivers. Additionally, prior encephalomalacia confers a heightened risk of recurrent , up to five-fold in patients with visible infarcts, due to underlying vascular vulnerabilities. Age at onset influences severity, with earlier insults generally yielding more profound deficits.

References

  1. [1]
  2. [2]
    Encephalomalacia from Physical Trauma in an Adult: A Case Report ...
    Oct 25, 2025 · Encephalomalacia is the loss of brain tissue caused by an insult to the cerebral matter. Encephalomalacia is not frequently described in ...
  3. [3]
    Clinical characteristics of cystic encephalomalacia in children - NIH
    May 22, 2024 · CE in children is mainly caused by HIE, intracranial infection, and cerebral hemorrhage. The major clinical manifestations included speech or motor ...
  4. [4]
    Parieto-occipital encephalomalacia in children; clinical and ... - NIH
    Epilepsy, psychomotor retardation, and visual problems were common neurologic complications.
  5. [5]
    Functional Recovery in a Patient of Abnormal Left Parieto-Occipital ...
    Feb 28, 2024 · Encephalomalacia is one kind of infection-related brain injury. It is a chronic condition after a brain injury and is categorized as a traumatic ...
  6. [6]
    Multicystic encephalomalacia: An autopsy report of 4 cases - PMC
    Nov 20, 2020 · The hypoxic insult results in liquefactive necrosis of the susceptible grey matter areas which eventually leave behind the cystic spaces.
  7. [7]
    Encephalomalacia from Physical Trauma in an Adult: A Case Report ...
    Oct 25, 2025 · There is currently no treatment to reverse encephalomalacia, as tissue loss is permanent. Current management primarily involves managing ...
  8. [8]
    Porencephaly - Global Radiology CME
    Jul 26, 2021 · Porencephaly is a rare congenital neurological disorder of the central nervous system that is characterized by encephalomalacia that communicates with the ...
  9. [9]
    Encephalomalacia - an overview | ScienceDirect Topics
    Encephalomalacia refers to softening of brain tissue, whether it is secondary to hemorrhagic contusion, infarction, or diffuse axonal injury.<|control11|><|separator|>
  10. [10]
    Historic review: select chapters of a history of stroke
    Dec 1, 2020 · ... Rostan came up with the idea that stroke must be the result of a softening of the brain (“ramollissement du cerveau”) [57]. In modern terms ...
  11. [11]
    Ramollissement (Six) - Stroke
    Jul 6, 2023 · Ramollissement – A peculiar disorganization or softening of the brain, which has now received that name – a term adopted from the French to ...
  12. [12]
    Richard Bright Advanced Research on Apoplexy, Stroke
    Jul 25, 2013 · With the first case in this group, Bright established that cerebral softening may be caused by cerebral congestion due to cerebral venous ...
  13. [13]
    Imaging of perfusion, angiogenesis, and tissue elasticity after stroke
    Apr 11, 2012 · ... 1820s by Rostan (1823) who called it ramollissement du cerveau, meaning 'softening of the brain' in French. Soon after, Abercrombie (1828) ...
  14. [14]
    Encephalomalacia | Radiology Reference Article | Radiopaedia.org
    Feb 13, 2024 · It should be distinguished from gliosis, where tissue remains present, and porencephaly where a circumscribed near-cystic space is present ...Multicystic encephalomalacia · Gliosis · Porencephaly · Right occipital lobe
  15. [15]
    From “apparent death” to “birth asphyxia”: a history of blame - Nature
    Nov 8, 2017 · The diagnosis “birth asphyxia” replaced the term “apparent death of the newborn” during the mass phobia of being buried alive in the eighteenth century.
  16. [16]
    Cell Liquefactive Necrosis - StatPearls - NCBI Bookshelf
    Jan 20, 2025 · The enzymes responsible for liquefaction are derived from bacterial or lysosomal hydrolytic enzymes. ... enzymes and constituents of neutrophils ...
  17. [17]
    Necrosis Pathology - StatPearls - NCBI Bookshelf - NIH
    2) Liquefactive necrosis: This morphology is most commonly observed in the central nervous system.[13] The dying cells are digested by hydrolytic enzymes and ...Missing: neutrophils macrophages
  18. [18]
    Cytotoxic edema: mechanisms of pathological cell swelling - PMC
    Cellular swelling begins within 30 minutes of MCA occlusion, particularly around capillaries, persists for up to 24 hours after reperfusion,, and results in an ...
  19. [19]
    Mitochondria in Ischemic Stroke: New Insight and Implications - PMC
    Mitochondrial dysfunction has been regarded as one of the hallmarks of ischemia/reperfusion (I/R) injury which induces neuronal death[9].4.1 Mitochondria Quality... · 4.2 Mitochondrial Dynamics... · 4.3 Mitophagy And Its Role...Missing: swelling | Show results with:swelling
  20. [20]
    Physiopathology of ischemic stroke and its modulation using ... - NIH
    Sep 22, 2020 · Excitotoxicity refers to damage caused by pathological depolarization due to the abnormal release of excitatory neurotransmitter glutamate and ...
  21. [21]
    The cell‐specific roles of Nrf2 in acute and chronic phases of ...
    Ischemic insults result in several forms of neuronal cell death. Necrosis owing to excitotoxicity is the predominant form in the ischemic core, while apoptosis ...
  22. [22]
    Glial scars are permeable to the neurotoxic environment of chronic ...
    Liquefactive necrosis occurs in abscesses throughout the body, and is usually caused by an inflammatory response to infection.
  23. [23]
    Astrocytes: biology and pathology - PMC - PubMed Central
    Descriptive features of reactive astrogliosis and glial scars. Although reactive astrogliosis is used widely as a pathological hallmark of diseased CNS tissue, ...
  24. [24]
    What the radiologist needs to know… - PubMed Central
    Oct 30, 2020 · Multilobar cystic encephalomalacia (as in Figure 25) is the result. There is usually marked ventriculomegaly because of ex vacuo dilatation from ...
  25. [25]
    Cerebrospinal fluid dynamics in non-acute post-traumatic ... - PubMed
    Mar 30, 2020 · Mild/moderate hydrocephalus, ex-vacuo ventriculomegaly/encephalomalacia were inconsistently reported in PTH patients. Conclusions: Rout and ...
  26. [26]
  27. [27]
    Experimental Imaging Study of Encephalomalacia Fluid-Attenuated ...
    Oct 31, 2021 · As there are no nerve cells in encephalomalacia, the lesion itself does not cause epilepsy. However, the scars (composed of glial cell ...
  28. [28]
    Intracranial calcifications on CT: an updated review - PMC
    ... encephalomalacia and scattered calcifications (6). Congenital toxoplasmosis is caused by transplacental transmission of Toxoplasma gondii with an incidence ...
  29. [29]
    Brain stones revisited—between a rock and a hard place - PMC
    This article provides a pictorial review illustrating various clinical entities resulting in brain stones.
  30. [30]
    Ischemic Stroke: Background, Anatomy, Pathophysiology
    Feb 21, 2024 · Nearly 800,000 people suffer strokes each year in the United States; 82–92% of these strokes are ischemic. Stroke is the fifth leading cause of ...
  31. [31]
    Ischemic Stroke - StatPearls - NCBI Bookshelf - NIH
    Feb 21, 2025 · As cerebral perfusion pressure decreases, cerebral blood vessels dilate in an attempt to augment cerebral blood flow.[19] However, if the ...
  32. [32]
    Encephalomalacia - an overview | ScienceDirect Topics
    Encephalomalacia is defined as the degeneration of brain tissue resulting from conditions such as hypoxia, ischemia, or toxic exposure, which lead to ...
  33. [33]
    Anatomical Variations in Circle of Willis in Patients Undergoing CT ...
    Dec 31, 2020 · Variations in Circle of Willis. Type of Variation, n (%). Hypoplasia of PCom, 33 (34.7). Aplasia of ...
  34. [34]
    Posterior communicating artery hypoplasia as a risk factor for acute ...
    Based on our results, PCoA hypoplasia appears to be a contributor to the risk of ischemic stroke, even in the absence of ICA occlusion.
  35. [35]
  36. [36]
    Susceptibility-weighted and diffusion kurtosis imaging to evaluate ...
    Apr 1, 2018 · Objective: Encephalomalacia after traumatic brain injury (TBI) is one of the factors leading to epilepsy. In this study, magnetic resonance ...
  37. [37]
    Multicystic encephalomalacia as an end-stage finding in abusive ...
    Five children, three boys and two girls (mean age 57 days, range 8-142 days) who developed cystic encephalomalacia after inflicted traumatic brain injury were ...
  38. [38]
    Vascular Abnormalities within Normal Appearing Tissue in Chronic ...
    Oct 1, 2018 · Trauma-induced encephalomalacia is frequently identified by its hyperintense appearance on fluid-attenuated inversion recovery (FLAIR) sequences ...
  39. [39]
    Brain tumour post-treatment imaging and treatment-related ...
    Nov 8, 2018 · The most common post-resection complication is iatrogenic stroke, with an estimated incidence of 1.6%. Iatrogenic stroke carries a nine-fold ...<|control11|><|separator|>
  40. [40]
    Encephalomalacia in the frontal lobe: complication of the ... - PubMed
    Encephalomalacia is the softening or loss of brain tissue after cerebral infarction, cerebral ischemia, infection, craniocerebral trauma, or other injury.
  41. [41]
    Clinical characteristics of cystic encephalomalacia in children
    May 21, 2024 · Purpose: To investigate the primary causes and clinical characteristics of cystic encephalomalacia (CE) in children.
  42. [42]
  43. [43]
    Brain Abscess - StatPearls - NCBI Bookshelf
    Sep 21, 2024 · A brain abscess is a localized area of necrosis within the brain parenchyma, often resulting from infectious agents, such as Staphylococcus and Streptococcus, ...
  44. [44]
    A case report of brain abscess caused by carbapenem-resistant ...
    Mar 24, 2023 · Encephalomalacia areas in the right frontoparietal were observed in the MRI taken in the 3 rd month after the completion of the treatment.
  45. [45]
    Cystic encephalomalacia and intrauterine herpes simplex virus ...
    Cystic encephalomalacia occurred in two preterm infants who had proven intrauterine herpes simplex virus type 2 infection. Calcification was evident in the ...<|separator|>
  46. [46]
    Cystic plaques in multiple sclerosis | Radiology Case
    Aug 21, 2012 · This is a patient with known multiple sclerosis. These cystic changes occur with necrosis/atrophy and are common in chronic MS lesions.
  47. [47]
    Hemorrhagic Transformation After Ischemic Stroke - PubMed Central
    Its mechanisms are usually explained by disruption of the blood-brain barrier and reperfusion injury that causes leakage of peripheral blood cells. In ischemic ...Missing: encephalomalacia | Show results with:encephalomalacia
  48. [48]
    Hemorrhagic transformation of ischemic stroke - Radiopaedia.org
    Jun 21, 2025 · Petechial hemorrhagic transformation has traditionally been referred to by pathologists as "red softening" in contrast to the more common bland ...MCA dot sign and... · Heidelberg bleeding... · Hemorrhagic transformation of...
  49. [49]
    Hemorrhagic transformation of ischemic stroke - MedLink Neurology
    Historically, hemorrhagic infarction, initially designated as "red softening ... It involves specific history, risk factors, symptoms, and pathology.
  50. [50]
    Ischemic stroke / infarct - Pathology Outlines
    Aug 3, 2023 · Hemorrhagic discoloration can be limited to a specific vascular territory · Commonly observed as secondary infarcts in the setting of brain ...
  51. [51]
    Pathogenesis of Hemorrhagic Infarction of the Brain - JAMA Network
    Fisher, C. M.: " The Pathology and Pathogenesis of Intracerebral Hemorrhage ... Fazio, C., and Sacchi, U.: Experimentally Produced Red Softening of the ...
  52. [52]
    Infarction - an overview | ScienceDirect Topics
    ... pale infarct. Red infarcts are suffused with blood and appear dark or bluish red. They occur in the following: ▫. Venous infarcts result from obstruction of ...
  53. [53]
    Watershed cerebral infarction | Radiology Reference Article
    Jul 22, 2025 · Watershed cerebral infarctions, also known as border zone infarcts, occur at the border between cerebral vascular territories where the tissue is furthest from ...Borderzone infarct · Internal watershed cerebral... · Internal watershed zone...Missing: encephalomalacia | Show results with:encephalomalacia
  54. [54]
    Cystic Encephalomalacia in a Young Woman After Cardiac Arrest ...
    Mar 31, 2022 · Cystic encephalomalacia is commonly reported in neonates with prenatal or perinatal hypoxic events. It is rarely observed in adults.
  55. [55]
    Abscess - Pathology Outlines
    Jan 6, 2022 · A brain abscess is a localized, pyogenic infection of brain parenchyma that occurs via direct spread of contiguous infections, ...Missing: yellow softening encephalomalacia
  56. [56]
    Cerebral aspergillosis in - Journal of Neurosurgery
    A clinical diagnosis of brain abscess was made ... Coronal section showing a large abscess in the right occipital lobe; it contained greenish yellow pus.
  57. [57]
    Thrombosis and Embolism (Seven) - Stroke
    Jul 6, 2023 · Rokitansky, in Vienna, had distinguished red, white, and yellow softening as separate categories of disease (Rokitansky (Reference Rokitansky ...
  58. [58]
    Brain abscess: An overview - ScienceDirect.com
    Opportunistic organisms which generally are not pathogenic to humans, cause brain abscess in immunocompromised patients. Antibiotics are given for 3–12 months.
  59. [59]
    Encephalomalacia | Radiology Reference Article | Radiopaedia.org
    Feb 13, 2024 · Encephalomalacia is the end result of liquefactive necrosis of brain parenchyma following insult, usually occurring after cerebral ischemia, cerebral infection ...Multicystic encephalomalacia · Gliosis · Porencephaly · Right occipital lobe
  60. [60]
    A Radiologist's Guide to Understanding Encephalomalacia - Medality
    May 25, 2025 · Encephalomalacia is the end result of liquefactive necrosis in the brain, commonly caused by infarction, hemorrhage, or trauma.Missing: treatment | Show results with:treatment
  61. [61]
    Multicystic encephalomalacia | Radiology Reference Article
    Oct 12, 2025 · It is a common feature observed in neonatal hypoxic-ischemic encephalopathy in a term neonate, including as a sequela of severe postnatal non- ...
  62. [62]
    Plasticity and Injury in the Developing Brain - PMC - PubMed Central
    A major difference between the nervous system in infants and children compared to adults is the capacity for greater plasticity in the developing brain. The ...
  63. [63]
  64. [64]
    Imaging in Chronic Traumatic Encephalopathy and Traumatic Brain ...
    On MRI, cystic encephalomalacia will be isointense to CSF, with surrounding gliosis appearing hyperintense on T2W sequences (Figure 9, B and C). Several ...
  65. [65]
    Angiocentric glioma mimicking encephalomalacia - PMC
    Mar 28, 2019 · Encephalomalacia is the end-stage of liquefactive necrosis and refers to loss of brain tissue as a result of multiple factors, including ...
  66. [66]
    Impact of Encephalomalacia and White Matter Hyperintensities on ...
    Encephalomalacia from old infarcts is an example of such an abnormality. Leukoaraiosis, which appears as white matter hyperintensities (WMH) on FLAIR MRI, also ...
  67. [67]
    Diffusion tensor magnetic resonance imaging of microstructural ...
    We present two pediatric cases demonstrating that diffusion tensor imaging is more efficient at revealing microstructural abnormalities of the brain than ...
  68. [68]
    FDG-PET imaging in mild traumatic brain injury: a critical review - PMC
    Jan 9, 2014 · FDG-PET shows a more severe injury with prominent hypometabolism frontally (arrow) associated with encephalomalacia. (C) 35 y.o. male, history ...
  69. [69]
    Liquefaction of the Brain following Stroke Shares a Similar ...
    Foamy macrophages within areas of liquefactive necrosis contain cholesterol crystals. A, Representative images of Fluoro-Jade C staining show degenerating ...
  70. [70]
    Cerebrum, subacute to remote infarct, microscopic - CNS Pathology
    This subacute cerebral infarction demonstrates the presence of many foamy macrophages at the right which are cleaning up the lipid debris from the liquefactive ...Missing: brain | Show results with:brain
  71. [71]
    Multicystic encephalomalacia as an end-stage finding in abusive ...
    MCE is mostly seen after severe asphyxia during the perinatal period and is thought to be caused by a hypoxic-ischemic event that causes brain damage.Missing: symptoms | Show results with:symptoms
  72. [72]
    Treatment of acute ischaemic stroke with thrombolysis or ... - PubMed
    Systemic thrombolysis with alteplase is the only approved medical treatment for patients with acute ischaemic stroke. Thrombectomy is also increasingly used ...Missing: encephalomalacia | Show results with:encephalomalacia
  73. [73]
    Treatment for ischemic stroke: From thrombolysis to thrombectomy ...
    Mar 27, 2019 · This mini-review summarizes the advancement in the treatment of ischemic stroke, from thrombolysis to thrombectomy and remaining challenges in the field.Missing: encephalomalacia | Show results with:encephalomalacia
  74. [74]
    Long-term antithrombotic therapy for the secondary prevention of ...
    Antiplatelet therapy reduces the incidence of stroke in patients at high risk for atherosclerosis and in those with known symptomatic cerebrovascular disease.
  75. [75]
    Surgical Management of Traumatic Acute Subdural Hematoma ... - NIH
    III. Surgical technique ... Commonly used surgical techniques for the evacuation of ASDH include cranioplastic craniotomy, large decompressive craniectomy, ...
  76. [76]
    Encephalitis - Treatment - NHS
    Possible treatments include: antiviral medicine – used if encephalitis is caused by the herpes simplex or chickenpox viruses; it's usually given into a vein ...Missing: encephalomalacia | Show results with:encephalomalacia
  77. [77]
    Encephalitis - Diagnosis and treatment - Mayo Clinic
    May 16, 2024 · Antiviral medicines · Acyclovir (Zovirax, Sitavig). · Ganciclovir. · Foscarnet (Foscavir).Missing: encephalomalacia | Show results with:encephalomalacia
  78. [78]
    Advances in endovascular aneurysm management: coiling and ...
    Mar 15, 2020 · Endovascular coiling remains a feasible and effective treatment option for the treatment of ruptured and unruptured aneurysms, especially as an ...
  79. [79]
    High-Dose Atorvastatin after Stroke or Transient Ischemic Attack
    Aug 10, 2006 · Statins reduce the incidence of strokes among patients at increased risk for cardiovascular disease; whether they reduce the risk of stroke ...
  80. [80]
    Management of post‐traumatic epilepsy: An evidence review over ...
    The aim of this rapid evidence review is to provide a synthesis of existing evidence on the effectiveness of treatment interventions for the prevention of PTE.
  81. [81]
    Therapeutic Hypothermia and Neuroprotection in Acute ...
    Dec 16, 2019 · Therapeutic hypothermia has consistently been shown to be a robust neuroprotectant in many labs studying different models of neurological disease.
  82. [82]
    Mechanical ventilation in patients with acute brain injury
    Nov 11, 2020 · Mechanical ventilation in patients with acute brain injury: recommendations of the European Society of Intensive Care Medicine consensus
  83. [83]
    Therapies to Restore Consciousness in Patients with Severe Brain ...
    The cornerstone of therapy is early intensive neurorehabilitation combining physical, occupational, speech/language, and neuropsychological therapy, which ...
  84. [84]
    The Power of Speech Therapy in Brain Injury Recovery
    Speech therapy can play a pivotal role in helping individuals with brain injury regain their ability to communicate.Missing: multidisciplinary encephalomalacia
  85. [85]
    Emotional & Mental Health - National Aphasia Association
    This page offers resources and pathways toward support and healing for people with aphasia and their care partners.
  86. [86]
    The association between lesion location and functional outcome ...
    Prognostically important locations include limbic, default-mode and language areas in the left hemisphere, and visuospatial and motor regions in the right ...Missing: eloquent | Show results with:eloquent
  87. [87]
    Screening of Risk Factors for Poor Prognosis in Patients with ...
    Jul 4, 2022 · Age, number of lesion sites, size of encephalomalacia, and seizure frequency are independent risk factors for the prognosis of patients with REAE.
  88. [88]
    The Impact of Diabetes on Outcomes After Acute Ischemic Stroke
    Patients with diabetes and AIS have more in-hospital complications, worse discharge outcomes, higher mortality and stroke recurrence at 90 days.
  89. [89]
    Hypertension and diabetes mellitus as a predictive risk factors for ...
    It can be established that hypertension and diabetes mellitus are a stroke risk factors and correlated in patients with atherosclerosis.
  90. [90]
    Intravenous Thrombolysis for Acute Ischemic Stroke Within 3 Hours ...
    Thrombolytic therapy given up to 6 hours after onset of symptoms significantly reduced the likelihood of death or dependency (mRS 3-6) at 3 to 6 months after ...
  91. [91]
    Epilepsy Associated with Encephalomalacia in Children.
    Sep 30, 2014 · In this study, we aimed to quantify the prevalence, clinical features, and risk factors of epilepsy associated with encephalomalacia.
  92. [92]
    Hydrocephalus | Pediatric Care Online - AAP Publications
    Sep 27, 2023 · Caused by hydrocephalus ex vacuo from encephalomalacia or by intracranial hypertension. Approximately 5% of these require permanent CSF ...
  93. [93]
    Psychosis in a case of encephalomalacia - PMC - PubMed Central
    Encephalomalacia is the softening or loss of brain tissue after cerebral infarction, cerebral ischemia, infection, craniocerebral trauma, or other injury.[1] In ...Missing: definition | Show results with:definition
  94. [94]
    [PDF] Moderate to Severe Traumatic Brain Injury is a Lifelong Condition
    Compared to people without TBI, people with. TBI are more likely to die from: 57% are moderately or severely disabled. 55%do not have a job (but were employed ...
  95. [95]
    Markers of Heightened Stroke Risk - RSNA
    Jun 10, 2025 · ... encephalomalacia and gliosis in ... But the presence of these brain infarcts may represent a five-fold increased risk of recurrent stroke.